Donepezil HCl
| Nom du produit | Donepezil HCl |
|---|---|
| Numéro CAS | 120011-70-3 |
| Synonymes | Donepezil hydrochloride, E2020, Aricept, (±)-2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride |
| Formule moléculaire | C24H29NO3·HCl |
| Poids moléculaire | 415.95 g/mol |
| Apparence | Poudre cristalline blanche à blanc cassé |
| Essai (HPLC) | 98.0% – 102.0% (on dried basis) |
| Solubilité | Soluble in water, methanol, and chloroform; slightly soluble in ethanol |
| Perte au séchage | ≤ 0,5% |
| Résidu au feu | ≤ 0,11 TP3T |
| Métaux lourds | ≤ 10 ppm |
| Colis | 25 kg fiber drum with double polyethylene bags |
Besoin d'aide ? Contacter notre équipe

Synonymes : Donepezil hydrochloride, E2020, Aricept, (±)-2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride
Donepezil HCl has become a staple in the portfolios of generic drug manufacturers and CDMOs targeting the central nervous system (CNS) segment. With the global rise in Alzheimer’s disease prevalence and the ongoing shift toward affordable generics, demand for this API remains robust across regulated and emerging markets alike.
Chemically, Donepezil HCl is a piperidine-based indanone derivative. It is the hydrochloride salt of donepezil, a reversible acetylcholinesterase inhibitor. The free base is a viscous oil, but the hydrochloride form offers the crystallinity and water solubility required for solid oral dosage forms.
LyvBio supplies Donepezil HCl in a single, high-purity grade suitable for immediate formulation into film-coated tablets. Our material is manufactured under cGMP conditions, with full traceability and regulatory support.
Donepezil HCl is a synthetic small molecule with a molecular weight of 415.95 g/mol. It is a white to off-white crystalline powder, freely soluble in water and methanol. The molecule contains a dimethoxyindanone moiety linked via a methylene bridge to a benzylpiperidine ring, a structure that confers high selectivity for acetylcholinesterase over butyrylcholinesterase.
Our production process yields a single polymorphic form, ensuring consistent dissolution and bioavailability across batches. Each lot is tested for assay, related substances, residual solvents, and particle size to meet the tight specifications of solid dosage manufacturing.
| Paramètre | Spécifications |
|---|---|
| Essai (HPLC) | 98.0% – 102.0% |
| Perte au séchage | ≤ 0,5% |
| Métaux lourds | ≤ 10 ppm |
| Résidu au feu | ≤ 0,11 TP3T |
| Limites microbiologiques | Nombre total de bactéries aérobies ≤ 1 000 UFC/g ; levures et moisissures ≤ 100 UFC/g ; absence d'E. coli |
| Granulométrie | D90 ≤ 50 µm (customizable) |
Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China